Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Randomized Double-Blind Placebo-controlled Single and Multiple Ascending Dose Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis or Atopic Dermatitis

NCT03733353 is registered in ClinicalTrials.gov with Evelo Biosciences, Inc. as lead sponsor.

NCT NCT03733353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03733353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Randomized Double-Blind Placebo-controlled Single and Multiple Ascending Dose Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis or Atopic Dermatitis
Lead sponsor
Evelo Biosciences, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 19, 2018
Completion date
October 29, 2021
Enrollment
204 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, psoriasis